Trials / Conditions / Locally Recurrent and Metastatic Breast Cancer
Locally Recurrent and Metastatic Breast Cancer
4 registered clinical trials studyying Locally Recurrent and Metastatic Breast Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer NCT00807859 | Amgen | Phase 1 |
| Completed | Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Br NCT00511459 | Amgen | Phase 2 |
| Terminated | A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer NCT00356681 | Amgen | Phase 2 |
| Completed | Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer NCT00322400 | Amgen | Phase 1 |